S&P 500   4,970.64 (-0.81%)
DOW   37,853.71 (+0.21%)
QQQ   415.91 (-1.77%)
AAPL   164.25 (-1.67%)
MSFT   398.79 (-1.36%)
META   482.93 (-3.76%)
GOOGL   153.41 (-1.67%)
AMZN   174.62 (-2.57%)
TSLA   148.76 (-0.78%)
NVDA   805.31 (-4.89%)
AMD   147.96 (-4.59%)
NIO   3.81 (-4.75%)
BABA   68.52 (-0.52%)
T   16.34 (+0.06%)
F   12.09 (+0.25%)
MU   106.97 (-4.43%)
GE   148.61 (-2.83%)
CGC   8.01 (+2.30%)
DIS   111.29 (-1.01%)
AMC   3.18 (+8.90%)
PFE   25.80 (+1.61%)
PYPL   61.77 (-0.53%)
XOM   119.89 (+1.16%)
S&P 500   4,970.64 (-0.81%)
DOW   37,853.71 (+0.21%)
QQQ   415.91 (-1.77%)
AAPL   164.25 (-1.67%)
MSFT   398.79 (-1.36%)
META   482.93 (-3.76%)
GOOGL   153.41 (-1.67%)
AMZN   174.62 (-2.57%)
TSLA   148.76 (-0.78%)
NVDA   805.31 (-4.89%)
AMD   147.96 (-4.59%)
NIO   3.81 (-4.75%)
BABA   68.52 (-0.52%)
T   16.34 (+0.06%)
F   12.09 (+0.25%)
MU   106.97 (-4.43%)
GE   148.61 (-2.83%)
CGC   8.01 (+2.30%)
DIS   111.29 (-1.01%)
AMC   3.18 (+8.90%)
PFE   25.80 (+1.61%)
PYPL   61.77 (-0.53%)
XOM   119.89 (+1.16%)
S&P 500   4,970.64 (-0.81%)
DOW   37,853.71 (+0.21%)
QQQ   415.91 (-1.77%)
AAPL   164.25 (-1.67%)
MSFT   398.79 (-1.36%)
META   482.93 (-3.76%)
GOOGL   153.41 (-1.67%)
AMZN   174.62 (-2.57%)
TSLA   148.76 (-0.78%)
NVDA   805.31 (-4.89%)
AMD   147.96 (-4.59%)
NIO   3.81 (-4.75%)
BABA   68.52 (-0.52%)
T   16.34 (+0.06%)
F   12.09 (+0.25%)
MU   106.97 (-4.43%)
GE   148.61 (-2.83%)
CGC   8.01 (+2.30%)
DIS   111.29 (-1.01%)
AMC   3.18 (+8.90%)
PFE   25.80 (+1.61%)
PYPL   61.77 (-0.53%)
XOM   119.89 (+1.16%)
S&P 500   4,970.64 (-0.81%)
DOW   37,853.71 (+0.21%)
QQQ   415.91 (-1.77%)
AAPL   164.25 (-1.67%)
MSFT   398.79 (-1.36%)
META   482.93 (-3.76%)
GOOGL   153.41 (-1.67%)
AMZN   174.62 (-2.57%)
TSLA   148.76 (-0.78%)
NVDA   805.31 (-4.89%)
AMD   147.96 (-4.59%)
NIO   3.81 (-4.75%)
BABA   68.52 (-0.52%)
T   16.34 (+0.06%)
F   12.09 (+0.25%)
MU   106.97 (-4.43%)
GE   148.61 (-2.83%)
CGC   8.01 (+2.30%)
DIS   111.29 (-1.01%)
AMC   3.18 (+8.90%)
PFE   25.80 (+1.61%)
PYPL   61.77 (-0.53%)
XOM   119.89 (+1.16%)
Free Trial

Integra LifeSciences (IART) Earnings Date, Estimates & Call Transcripts

→ Healthcare Takes A Big Step Forward With The Help Of AI (From The Bull Report) (Ad)
Free IART Stock Alerts
$29.09
-2.54 (-8.03%)
(As of 12:21 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability

Earnings Summary

Upcoming
Earnings Date
May. 6
Before Market Opens
Confirmed
Actual EPS
(Feb. 28)
$0.89 Missed By -$0.01
Consensus EPS
(Feb. 28)
$0.90
Read Call Transcript
Listen to Call
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

IART Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

IART Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Integra LifeSciences Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20241$0.55$0.55$0.550.530 - 0.570
Q2 20241$0.74$0.74$0.74 
Q3 20241$0.87$0.87$0.87 
Q4 20241$1.00$1.00$1.00 
FY 20244$3.16$3.16$3.16 
Q1 20251$0.74$0.74$0.74 
Q2 20251$0.76$0.76$0.76 
Q3 20251$0.98$0.98$0.98 
Q4 20251$1.03$1.03$1.03 
FY 20254$3.51$3.51$3.51 
Q1 20261$0.72$0.72$0.72 

IART Earnings Date and Information

Integra LifeSciences last issued its earnings results on February 28th, 2024. The life sciences company reported $0.89 earnings per share for the quarter, missing the consensus estimate of $0.90 by $0.01. The business had revenue of $397 million for the quarter, compared to analyst estimates of $399.30 million. Its revenue was down .3% on a year-over-year basis. Integra LifeSciences has generated $0.83 earnings per share over the last year ($0.83 diluted earnings per share) and currently has a price-to-earnings ratio of 38.1. Earnings for Integra LifeSciences are expected to grow by 13.17% in the coming year, from $3.19 to $3.61 per share. Integra LifeSciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 24th, 2024 based off prior year's report dates.

Integra LifeSciences Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/6/2024
Confirmed)		-------  
2/28/2024Q4 2023$0.90$0.89($0.01)$1.53$399.30 million$397.00 million    
10/25/2023Q3 2023$0.78$0.76($0.02)$1.28$387.22 million$382.40 million      
7/26/2023Q2 2023$0.57$0.71+$0.14$1.37$388.79 million$381.30 million      
4/26/2023Q1 2023$0.74$0.74-$1.19$373.21 million$380.85 million    
2/22/2023Q4 2022$0.93$0.94+$0.01$1.25$398.57 million$398.00 million    
10/26/2022Q3 2022$0.72$0.86+$0.14$1.12$377.79 million$385.19 million
7/27/2022Q2 2022$0.80$0.82+$0.02$1.10$394.54 million$397.82 million
4/27/2022Q1 2022$0.68$0.74+$0.06$1.09$362.19 million$376.60 million      
2/23/2022Q4 2021$0.83$0.84+$0.01$1.15$403.41 million$405.52 million    
11/1/2021Q3 2021$0.72$0.86+$0.14$1.21$384.47 million$386.86 million    
7/27/2021Q2 2021$0.66$0.79+$0.13$1.17$376.11 million$389.99 million    
4/27/2021Q1 2021$0.57$0.69+$0.12$0.85$349.78 million$360.10 million  

Integra LifeSciences Earnings - Frequently Asked Questions

When is Integra LifeSciences's earnings date?

Integra LifeSciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 24th, 2024 based off last year's report dates. Learn more on IART's earnings history.

Did Integra LifeSciences beat their earnings estimates last quarter?

In the previous quarter, Integra LifeSciences (NASDAQ:IART) missed the analysts' consensus estimate of $0.90 by $0.01 with a reported earnings per share (EPS) of $0.89. Learn more on analysts' earnings estimate vs. IART's actual earnings.

How can I listen to Integra LifeSciences's earnings conference call?

The conference call for Integra LifeSciences's latest earnings report can be listened to online. Listen to Conference Call

How can I read Integra LifeSciences's conference call transcript?

The conference call transcript for Integra LifeSciences's latest earnings report can be read online. Read Transcript

How much revenue does Integra LifeSciences generate each year?

Integra LifeSciences (NASDAQ:IART) has a recorded annual revenue of $1.54 billion.

How much profit does Integra LifeSciences generate each year?

Integra LifeSciences (NASDAQ:IART) has a recorded net income of $67.74 million. IART has generated $0.83 earnings per share over the last four quarters.

What is Integra LifeSciences's price-to-earnings ratio?

Integra LifeSciences (NASDAQ:IART) has a trailing price-to-earnings ratio of 38.11 and a forward price-to-earnings ratio of 9.92. The price/earnings-to-growth ratio is 0.96.

What is Integra LifeSciences's EPS forecast for next year?

Integra LifeSciences's earnings are expected to grow from $3.19 per share to $3.61 per share in the next year, which is a 13.17% increase.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:IART) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden’s $374B Giveaway Into This Sector
DTI
The #1 Crypto for 2024
InvestorPlace
He Is Giving Away Bitcoin
Crypto Swap Profits
Urgent alert: open this for a huge profit potential
Timothy Sykes
1970’s computer coder issues shocking A.I. warning
TradeSmith